MCM
CLBT icon

Massar Capital Management’s Cellebrite CLBT Stock Holding History

Massar Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$597K Sell
40,876
-127,572
-76% -$1.69M 0.06% 138
2026
Q1 		$2.32M Buy
+168,448
New +$2.54M 0.25% 60

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Massar Capital Management's CLBT Position: Q2 2026 in Review

Massar Capital Management reduced its Cellebrite (CLBT) stake by 76% in Q2 2026, selling an estimated $1.69M and leaving 40,876 shares worth $597K. The position accounts for 0.06% of the portfolio, ranked #138.

Massar Capital Management first reported a position in CLBT in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.32M in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Massar Capital Management held 40,876 shares of Cellebrite worth $597K as of Q2 2026.
  • Massar Capital Management sold 127,572 Cellebrite shares in Q2 2026, an estimated $1.69M.
  • Cellebrite made up 0.06% of Massar Capital Management's portfolio in Q2 2026, its #138 holding.
  • Massar Capital Management first reported a position in Cellebrite in Q1 2026 and has held it in 2 quarters since.
  • Massar Capital Management's Cellebrite position peaked at $2.32M in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Massar Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.